Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients with Diabetes: A Double-Blind Randomized Controlled Trial

Dermatology. 2021;237(1):66-69. doi: 10.1159/000502130. Epub 2019 Aug 30.

Maeve Lynch^{1

2}, Anna Malara³, Irene Timoney⁴, Tomas Ahern⁵, Fatima Awdeh⁴, Cheryl Sweeney³, Marie Galligan³, Sebastian Venckens³, Genevieve Kelly⁴, Rosalind Hughes⁴, Donal O Apos Shea^{3

5}, Peter Doran⁶, Brian Kirby^{4

3}

¹ Department of Dermatology, St. Vincent's University Hospital, Dublin, Ireland, lynchmaeve@yahoo.ie.
² School of Health Sciences and Charles Institute, University College Dublin, Dublin, Ireland, lynchmaeve@yahoo.ie.
³ School of Health Sciences and Charles Institute, University College Dublin, Dublin, Ireland.
⁴ Department of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.
⁵ Department of Endocrinology, St. Vincent's University Hospital, Dublin, Ireland.
⁶ Clinical Research Centre, University College Dublin, Dublin, Ireland.

No abstract available

Keywords: Gliclazide; Psoriasis; Sitagliptin; Type 2 diabetes mellitus.

Publication types